Kevin Gallagher

Kevin Gallagher has over 35 years of work experience in the pharmaceutical industry. Kevin is currently working as Senior Director, Market Access at Fennec Pharmaceuticals Inc since April 2022. Prior to that, they worked as National Account Director at Orphazyme A/S from 2020 to 2021. From 2017 to 2019, they served as Senior National Account Director at Melinta Therapeutics. Kevin also held the position of Account Director at AstraZeneca from 2014 to 2017 and Regional Account Manager at MedImmune from 2010 to 2014. Before joining MedImmune, they were the Corporate Account Manager at Prostrakan Inc from 2009 to 2010 and the Division Manager at Roche from 2005 to 2007. Kevin has a long tenure at AstraZeneca, where they worked as Regional Sales Director from 2000 to 2005, District Manager from 1997 to 2000, and Sales Representative, Trainer, and Business Manager from 1992 to 1997. Kevin started their career as a Sales Representative at Merck from 1988 to 1992 and at NATIONAL HEALTH LABORATORIES INC from 1986 to 1988.

Kevin Gallagher has a Master of Management degree from Northwestern University - Kellogg School of Management. Kevin'sMBA focused on marketing, health services management, and organizational behavior. Additionally, they hold a Bachelor of Science degree in Chiropody/Podiatry from Glasgow Caledonian University (formerly known as Glasgow School of Chiropody). Kevin is also a registered chiropodist/podiatrist.